tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GPCR Stock Latest News

Structure Therapeutics Reports Strong Q3 2024 Results
Company AnnouncementsStructure Therapeutics Reports Strong Q3 2024 Results
10d ago
GPCR
Structure Therapeutics expects cash to fund operations through at least 2027
PremiumThe Fly
Structure Therapeutics expects cash to fund operations through at least 2027
10d ago
GPCR
Structure Therapeutics doses first patients in ACCESS clinical study
PremiumThe Fly
Structure Therapeutics doses first patients in ACCESS clinical study
10d ago
GPCR
Is GPCR a Buy, Before Earnings?
PremiumPre-Earnings
Is GPCR a Buy, Before Earnings?
13d ago
GPCR
3 Best Stocks to Buy Now, 9/23/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 9/23/2024, According to Top Analysts 
2M ago
SKX
GPCR
Structure Therapeutics initiated with an Overweight at Morgan Stanley
PremiumThe FlyStructure Therapeutics initiated with an Overweight at Morgan Stanley
2M ago
GPCR
Structure Therapeutics Announces Key Executive Leadership Changes
Premium
Company Announcements
Structure Therapeutics Announces Key Executive Leadership Changes
2M ago
8K
GPCR
Structure Therapeutics CMO Mark Bach to leave role, Blai Coll to succed
Premium
The Fly
Structure Therapeutics CMO Mark Bach to leave role, Blai Coll to succed
2M ago
GPCR
Statement from President Biden on anti-obesity medications pricing
PremiumThe Fly
Statement from President Biden on anti-obesity medications pricing
3M ago
AZN
LLY
Structure Therapeutics Appoints Angus Russell to Board
PremiumCompany Announcements
Structure Therapeutics Appoints Angus Russell to Board
3M ago
8K
GPCR
Structure Therapeutics price target lowered to $86 from $91 at JMP Securities
PremiumThe Fly
Structure Therapeutics price target lowered to $86 from $91 at JMP Securities
4M ago
GPCR
Structure Therapeutics reports Q2 net loss of $26.03M
PremiumThe Fly
Structure Therapeutics reports Q2 net loss of $26.03M
4M ago
GPCR
B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
PremiumThe FlyB. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
4M ago
ALT
PFE
Structure Therapeutics recent selloff ‘highly overdone,’ says Cantor Fitzgerald
Premium
The Fly
Structure Therapeutics recent selloff ‘highly overdone,’ says Cantor Fitzgerald
5M ago
LLY
GPCR
Structure Therapeutics price target raised to $100 from $83 at BMO Capital
Premium
The Fly
Structure Therapeutics price target raised to $100 from $83 at BMO Capital
6M ago
LLY
GPCR
Structure Therapeutics 9.07M share Secondary priced at $52.50
PremiumThe Fly
Structure Therapeutics 9.07M share Secondary priced at $52.50
6M ago
GPCR
Structure Therapeutics announces offering of 8M American depositary shares
PremiumThe Fly
Structure Therapeutics announces offering of 8M American depositary shares
6M ago
GPCR
Structure Therapeutics files to sell 8M ADSs representing 24M ordinary shares
PremiumThe Fly
Structure Therapeutics files to sell 8M ADSs representing 24M ordinary shares
6M ago
GPCR
Structure Therapeutics Reports Breakthrough in Obesity Study
PremiumCompany Announcements
Structure Therapeutics Reports Breakthrough in Obesity Study
6M ago
8K
GPCR
Structure Therapeutics announces data from Phase 2a obesity study, PK study
PremiumThe FlyStructure Therapeutics announces data from Phase 2a obesity study, PK study
6M ago
GPCR
J.P. Morgan Predicts up to 210% Gains for These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
J.P. Morgan Predicts up to 210% Gains for These 2 ‘Strong Buy’ Stocks
6M ago
GPCR
KYTX
Structure Therapeutics (NASDAQ:GPCR): Analysts See 130% Upside in This GLP-1 Stock
Premium
Market News
Structure Therapeutics (NASDAQ:GPCR): Analysts See 130% Upside in This GLP-1 Stock
6M ago
LLY
NVO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >